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Abstract
Asthma is the most common chronic respiratory illness among 
pediatric populations.1 An asthma exacerbation, otherwise known as 
an acute attack is the leading cause of morbidity in children resulting 
in missed time from activities, increased absence from school, and 
increased healthcare costs.2 In general, more frequent and severe 
exacerbations requiring urgent attention or medical care indicates 
poorer control. 
Vitamin D has long been established as a requirement for proper 
skeletal growth and development; however it also modifies the 
inflammatory response by our immune system.3 Its role in asthma is 
not yet clear, and few studies have proposed a possible link between 
vitamin D supplementation and decreased airway inflammation.
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Introduction
Methods
A literature search using PubMed and Google Scholar was carried out in 
November 2018. Six articles including randomized control trials and systematic 
reviews were chosen. These articles were included based on their intervention, 
patient population, outcome measures and publication date. The results of each 
article were further analyzed, and compared.
Given an increase in the prevalence of childhood asthma and the 
detrimental effects from acute exacerbations, researching alternative 
treatments to control symptoms is of high clinical importance. Most of 
the studies found vitamin D supplementation compared to standard of 
care alone significantly reduced acute exacerbations, decreased the 
need for ED visits, and decreased the dose of systemic corticosteroids 
used. Trials also found that children supplemented with vitamin D had 
earlier control of asthma symptoms. 
RCT were limited by small sample sizes, short treatment timelines, and 
varying baseline vitamin D levels in pediatric patients. In order to elicit 
a respiratory response, it is recommended that future studies give the 
treatment group a high enough dose of vitamin D for a significant 
amount of time to maintain serum vitamin D levels > 30 ng/mL.
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Current asthma management includes a SABA for quick symptomatic 
relief and ICS for longer lasting support. Vitamin D supplementation 
may contribute to the prevention of acute asthma exacerbations due 
to its ability to modify the inflammatory response on airway 
epithelium. There is some evidence that vitamin D has a protective 
effect on airway hypersensitivity, providing better control of 
symptoms and improving quality of life. However, the role of vitamin 
D supplementation in asthma remains unclear. 
Future trials are needed in order to:
ü standardize the definition of acute exacerbation
ü include larger sample sizes
ü supplement a high enough dose to elicit non-skeletal effects of 
vitamin D
Conclusion
After the literature review, 4 randomized control trials (RCT) 
and 2 systematic reviews were chosen. 
§ Yadav et al found that vitamin D supplementation helped 
children achieve earlier control of symptoms and reduce 
overall severity of symptoms after 6 months when 
compared to placebo. 
§ Five out of the six articles found a significant decrease in 
acute exacerbations in children receiving vitamin D. 
§ Three studies suggested better control of disease 
decreased the amount of emergency department (ED) 
visits and steroid usage in children with moderate-to-
severe asthma. 
§ There was no significant change in pulmonary function 
tests (FEV1) between the vitamin D group and placebo 
group. 
Asthma is a chronic respiratory disorder characterized by:
1. Reversible obstruction of airflow
2. Airway hypersensitivity
3. Inflammation of the airways
Much of the burden of disease is a consequence of acute exacerbations 
which often present as cough, chest tightness and wheezing. First-line 
medications prescribed to treat symptoms include a short-acting beta-
agonist (SABA) and inhaled corticosteroids (ICS). Vitamin D has been 
shown to be a potent immunomodulator in several disease states, 
supporting a theory that high circulation levels would decrease airway 
spasm and irritation. For children and adolescents diagnosed with 
moderate-severe asthma, vitamin D may play a protective role in 
decreasing airway hypersensitivity, thus preventing acute exacerbations. 
This straightforward, inexpensive intervention may provide a significant 
therapeutic improvement in asthma.
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Table 1. Comparison of Results
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